Correct Endotracheal Tube Position in Newborns Intubated in the Delivery Room (Intubated-DR)

June 12, 2021 updated by: Tania Carbayo Jiménez

Correct Endotracheal Tube Position in Newborns Intubated in the Delivery Room According to Two Different Methods Based on Estimated Birth Weight. Randomized Clinical Trial (NeoTEDI)

The investigators wished to determine whether estimating endotracheal tube (ETT) insertion depth using the formula given by Spanish guidelines recommendations (5,5 plus weight) rather than the depth using the formula given by international guidelines recommendations (6 plus weight) resulted in more correctly positioned endotracheal tube tips in newborns intubated in the delivery room.

Study Overview

Detailed Description

A number of different methods have been used to guide clinicians in estimating the correct depth of insertion of endotracheal tube (ETT) at the time of oral intubation. Minor differences in tube length may lead to intubation of the right main bronchus or extubation. However, none of them has shown to be better than others when compared in the context of randomized clinical trials.

Commonly, clinicians use a formula based on the newborn's weight (Tochen formula: ETT insertion depth (cm)=6 + wt (kg)). While this method is widely used and recommended by international guidelines, it has been found to frequently result in incorrectly positioned tubes, especially in infants <1000 g in weight in whom it may lead to overestimation of ETT insertion depth.

On the other hand, Spanish Society of Neonatology recommended in their last published guidelines (2017) to use an alternative version formula (ETT insertion depth (cm)=5.5 + wt (kg)), which is commonly used among Spanish neonatal units.

Finally, no studies have been performed in newborns who require oral intubation in the delivery room, since these intubations are usually excluded because infants are not routinely weighed prior to resuscitation and weight can not be rapidly obtained. Given that Obstetric Unit in our hospital is a high standard one with a highly reliable estimated fetal weight in prenatal ultrasound, the investigators will use estimated fetal weight referred on ultrasounds or 50th percentile for gestational age for calculations.

Study Type

Interventional

Enrollment (Anticipated)

280

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Madrid, Spain, 28041
        • Recruiting
        • Hospital Universitario 12 de Octubre. Neonatology Department.
        • Contact:
          • María Soriano-Ramos, M.D.
          • Phone Number: 0034 91390 8272

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

No older than 1 day (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • All newborns requiring endotracheal oral intubation in the delivery room after birth.
  • Parents accept deferred informed consent to participate in the study.

Exclusion Criteria:

  • Prior to randomization
  • Uncontrolled gestation where both estimated fetal weight and gestational age are unknown.
  • Upper airway anomaly or a lung anomaly that would distort the upper airway anatomy.
  • Infants who require nasotracheal intubation
  • Infants who are intubated in the Neonatal Intensive Care Unit
  • Post-randomization
  • Newborns who are randomized but finally do not require intubation
  • Intubated newborns who are electively extubated in the delivery room
  • Parents / legal guardian refuse to give consent to participate in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention Group (5.5 plus weight)
ETT insertion depth using Spanish recommendations Patients included in the intervention group arm who are included in the study will be intubated using Spanish recommendations (5.5 plus weight) to estimate insertion endotracheal tube depth. In addition, every arm will be divided into 2 subgroups depending on gestational age (under 32 weeks or equal/over 32 weeks' gestation).
Infants included in this assignment group will be intubated using the formula 5.5 plus weight, when requiring oral intubation in the delivery room.
Experimental: Control Group (6 plus weight)
ETT insertion depth using international recommendations Patients included in the intervention group arm who are included in the study will be intubated using international recommendations (6 plus weight) to estimate insertion endotracheal tube depth. In addition, every arm will be divided into 2 subgroups depending on gestational age (under 32 weeks or equal/over 32 weeks' gestation).
Infants included in this assignment group will be intubated using the formula 6 plus weight, when requiring oral intubation in the delivery room.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Frequency of correct endotracheal tube (ETT) position
Time Frame: 1 hour
Correct ETT position, that is, tip between the upper border of the first thoracic vertebra (T1) and the lower border of the second thoracic vertebra (T2) on a chest X-ray as determined by one pediatric radiologist masked to group assignment.
1 hour

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of intubation attempts in the delivery room
Time Frame: 2 days
Number of intubation attempts in the delivery room by healthcare professionals
2 days
Number of accidental extubations prior to chest X-ray
Time Frame: 2 days
Number of accidental extubations prior to chest X-ray confirmation of ETT position
2 days
Frequency of ETT repositioning prior and after chest X-ray
Time Frame: 2 days
ETT repositioning prior and after chest X-ray
2 days
Frequency of incorrect ETT position
Time Frame: 2 days
Incorrect ETT position (too low or too high)
2 days
Frequency of complications secondary to incorrect ETT position
Time Frame: 7 days
Complications secondary to incorrect ETT position (air leak, unplanned extubation, atelectasis)
7 days
Professional healthcare sensation about correct or incorrect ETT position
Time Frame: 1 day
Professional healthcare sensation about correct or incorrect ETT position, before confirmation with Chest X-ray confirmation
1 day
Duration of ventilation
Time Frame: 3 months
Duration of ventilation in days
3 months
Oxygen therapy at 28 days
Time Frame: 1 month
Oxygen therapy at 28 days
1 month
Oxygen therapy at 36 weeks postmenstrual age
Time Frame: 3 months
Oxygen therapy at 36 weeks postmenstrual age
3 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Presence of intraventricular hemorrhage or central nervous system lesion
Time Frame: 3 months
Presence of intraventricular hemorrhage or central nervous system lesion
3 months
Death before discharge from the hospital
Time Frame: 4 months
Death before discharge from the hospital
4 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Tania Carbayo Jimenez, M.D., Hospital Universitario 12 de Octubre

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2019

Primary Completion (Anticipated)

January 1, 2022

Study Completion (Anticipated)

January 1, 2022

Study Registration Dates

First Submitted

December 5, 2018

First Submitted That Met QC Criteria

December 7, 2018

First Posted (Actual)

December 10, 2018

Study Record Updates

Last Update Posted (Actual)

June 16, 2021

Last Update Submitted That Met QC Criteria

June 12, 2021

Last Verified

June 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • Neo TEDI

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Intubation Complication

3
Subscribe